FDA Enforcement Class II Terminated

DrugSmart 11 Test Cup, Item No. 61127D; DrugSmart 12 Test Cup (Multi & BUP), Item No. 61210D; DrugSmart 9 Test Cup (BUP), Item No. 60960D; DrugSmart Cup 10, Item No. 61093D-3C These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use.

Recall: Z-0308-2016 · Reported November 25, 2015

Enforcement

Recall Number
Z-0308-2016
Event ID
72471
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Ameditech Inc
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
November 25, 2015
Initiation Date
October 20, 2015
Classification Date
November 18, 2015
Termination Date
November 9, 2016
Address
9940 Mesa Rim Rd, N/A, San Diego, CA, 92121-2910, United States

Description

DrugSmart 11 Test Cup, Item No. 61127D; DrugSmart 12 Test Cup (Multi & BUP), Item No. 61210D; DrugSmart 9 Test Cup (BUP), Item No. 60960D; DrugSmart Cup 10, Item No. 61093D-3C These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use.

Reason

Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

Code Info

140770 142294 151050 151527 142527 140998 142526 150596 151122 151196

Distribution

Worldwide Distribution - US (nationwide) and Internationally to Australia.

Quantity

1220 units